Vertex Pharmaceuticals · 1 month ago
Senior Director, Global Development Financial Planning & Analysis
Boston, MA
Full-time
Hybrid
Director/Executive
$212K/yr - $318K/yr
12+ years expVertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Senior Director, Global Development FP&A is a seasoned finance leader responsible for global financial planning, forecasting, and strategic analysis, partnering with clinical development teams to drive financial insights and support decision-making.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Build, maintain, and own clinical program-level budgets (Phase 1 to Phase 3), clinical trial cost models, and forecasts; produce cost-to-complete and cost per patient analysis used in strategic decisions
Lead advanced scenario modeling for clinical programs, including sensitivity analyses on timelines, enrollment rates, and regulatory milestones to inform go/no-go decisions
Translate clinical development plans into financial implications and ROI-based recommendations
Participate in cross-functional program teams and governance committees, providing real-time financial guidance
Deliver program dashboards, KPIs and trend analyses for executive and portfolio reviews
Prepare and present executive-level updates
Lead and develop a team of 6-8 clinical finance professionals: set team priorities, establish processes, and build scalable operating mechanisms for financial support
Drive automation and digital transformation of clinical finance processes, leveraging tools like Hyperion, Oracle, and emerging analytics platforms to improve accuracy and scalability
Mentor staff on forecast accuracy, stakeholder management and financial modeling best practices
Drive a collaborative, service-oriented culture between finance and Global Clinical Development organizations
Oversee month-end and quarter-end close activities related to clinical expense (accruals, reconciliations, GL review)
Ensure accurate, timely accruals for CROs, FSPs, sites, labs and other clinical vendors. Maintain audit-ready documentation for clinical program spend
Improve transparency and accountability around clinical opex and resource allocation through clear processes, benchmarks and metrics
Qualification
Required
Bachelor's degree in finance, Accounting, or related field
12+ years of progressive FP&A experience, with at least 5 years in the pharmaceutical or biotech industry
Experience supporting R&D or Clinical Development functions at a global scale
Strong understanding of R&D processes, portfolio management, and project evaluation methodologies
Proven ability to manage complex budgets, forecasts, and analyses in a dynamic, fast-paced environment
Excellent communication and presentation skills, with the ability to influence stakeholders at all levels and a proven ability to present complex financial insights to senior stakeholders
Deep understanding of pharmaceutical industry dynamics and executive-level business partnering
Hands-on exposure to clinical operations and/or CRO/FSP budgeting
Strong analytical capabilities in portfolio analysis
Proficiency in Microsoft Office and financial systems, including Hyperion and Oracle
Proven ability to lead change in complex, cross-cultural matrix environments
Exceptional communication and influencing skills across senior leadership and cross-functional teams
Ability to apply broad market knowledge to drive financial performance and strategic outcomes
Strategic thinker with attention to detail
Preferred
MBA or CPA/CFA strongly preferred
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-23
Benzinga.com
2026-01-23
2026-01-22
Company data provided by crunchbase